SCHEMBL12408413

SCHEMBL12408413

[C-]#[N+]c1c[nH]c(C(=O)Nc2ccc(C3CN(CCC)C(=O)N(CCO)C3)cc2C2=CCCCC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 20/20 0.50
▸ KIT P10721 7/20 0.48
▸ NTRK1 P04629 4/20 0.44
▸ LCK P06239 4/20 0.44
▸ AXL P30530 4/20 0.44
▸ FLT3 P36888 4/20 0.44
▸ CYP3A4 P08684 5/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ BMPR1B O00238 2/20 0.42
▸ PLK4 O00444 2/20 0.42
▸ STK25 O00506 2/20 0.42
▸ RIOK3 O14730 2/20 0.42
▸ CHEK1 O14757 2/20 0.42
▸ GAK O14976 2/20 0.42
▸ DCLK1 O15075 2/20 0.42
▸ MUSK O15146 2/20 0.42
▸ EPHB6 O15197 2/20 0.42
▸ PDPK1 O15530 2/20 0.42
▸ MAP3K13 O43283 2/20 0.42
▸ DAPK3 O43293 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12408113 0.96 CSF1R (0.51) CSF1RKITNTRK1LCKAXL
SCHEMBL12408023 0.87 CSF1R (0.64) CSF1RKITNTRK1LCKAXL
SCHEMBL1859834 0.83 CSF1R (0.59) CSF1RKITNTRK1LCKAXL
SCHEMBL12482770 0.81 CSF1R (0.56) CSF1RKITNTRK1LCKAXL
SCHEMBL12408090 0.80 CSF1R (0.62) CSF1RKITCYP2C19
SCHEMBL12408115 0.79 CSF1R (0.54) CSF1RKIT
SCHEMBL12408096 0.78 CSF1R (0.52) CSF1RKITCYP3A4CYP2C19
SCHEMBL12408117 0.76 CSF1R (0.54) CSF1RKITNTRK1LCKAXL
SCHEMBL12408018 0.76 CSF1R (0.68) CSF1RKITNTRK1LCKAXL
SCHEMBL12408099 0.75 CSF1R (0.47) CSF1RKITNTRK1LCKAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973035-B2 Inhibitors of C-FMS kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2011-07-05 — — US disclosed
Send feedback